1. Search Result

Search Result

Results for "1240305-17-2" in MCE Product Catalog:

Cat. No. Product Name Target Research Area
  • HY-114308
    SGL5213

    SGLT Metabolic Disease
    SGL5213 is a potent, oral active and low-absorbable sodium-dependent glucose cotransporter 1 (SGLT1) inhibitor, with IC50 values of 29 nM and 20 nM for hSGLT1 and hSGLT2, respectively. SGL5213 has potential to treat type 2 diabetes treatment.